Improvement of Oral Bioavailability and Anti-Tumor Effect of Zingerone Self-Microemulsion Drug Delivery System

被引:31
作者
Cao, Xia [1 ]
Zhu, Qin [1 ]
Wang, Qi-Long [1 ]
Adu-Frimpong, Michael [2 ]
Wei, Chun-Mei [1 ]
Weng, Wen [1 ]
Bao, Rui [1 ]
Wang, Ya-Ping [1 ]
Yu, Jiang-Nan [1 ]
Xu, Xi Ming [1 ]
机构
[1] Jiangsu Univ, Ctr Nano Drug Gene Delivery & Tissue Engn, Sch Pharm, Dept Pharmaceut, Zhenjiang, Jiangsu, Peoples R China
[2] Kwame Nkrumah Univ Sci & Technol, Dept Biochem & Biotechnol, Kumasi, Ghana
基金
中国国家自然科学基金;
关键词
Zingerone; Self-emulsifying; Pharmacokinetic; Oral drug delivery; Bioavailability apoptosis; IN-VITRO; ZINGIBER-OFFICINALE; OXIDATIVE STRESS; FORMULATION; SMEDDS; ANTICANCER; PERMEABILITY; INFLAMMATION; ENHANCEMENT; OIL;
D O I
10.1016/j.xphs.2021.01.037
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This study sought to prepare a self-microemulsion drug delivery system containing zingerone (ZSMEDDS) to improve the low oral bioavailability of zingerone and anti-tumor effect. Z-SMEDDS was characterized by particle size, zeta potential and encapsulation efficiency, while its pharmacokinetics and anti-tumor effects were also evaluated. Z-SMEDDS had stable physicochemical properties, including average particle size of 17.29 +/- 0.07 nm, the zeta potential of -22.81 +/- 0.29 mV, and the encapsulation efficiency of 97.96% +/- 0.02%. In vitro release studies have shown the release of zingerone released by ZSMEDDS was significantly higher than free zingerone in different release media. The relative oral bioavailability of Z-SMEDDS was 7.63 times compared with free drug. Meanwhile, the half inhibitory concentration (IC50)of Z-SMEDDS and free zingerone was 8.45 mg/mL and 13.30 mg/mL, respectively on HepG2. This study may provide a preliminary basis for further clinical research and application of ZSMEDDS. (C) 2021 Published by Elsevier Inc. on behalf of the American Pharmacists Association.
引用
收藏
页码:2718 / 2727
页数:10
相关论文
共 52 条
[1]   Novel cuminaldehyde self-emulsified nanoemulsion for enhanced antihepatotoxicity in carbon tetrachloride-treated mice [J].
Adu-Frimpong, Michael ;
Wei Qiuyu ;
Firempong, Caleb Kesse ;
Mukhtar, Yusif Mohammed ;
Yang, Qiuxuan ;
Omari-Siaw, Emmanuel ;
Zhen Lijun ;
Xu, Ximing ;
Yu, Jiangnan .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (08) :1324-1338
[2]   Protective effects of zingerone on oxidative stress and inflammation in cisplatin-induced rat nephrotoxicity [J].
Alibakhshi, Tuba ;
Khodayar, Mohammad Javad ;
Khorsandi, Layasadat ;
Rashno, Mohammad ;
Zeidooni, Leila .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 105 :225-232
[3]  
Amresh Gupta, 2018, J Tradit Complement Med, V8, P164, DOI 10.1016/j.jtcme.2017.05.005
[4]   Bio-plasticizer production by hybrid acetone-butanol-ethanol fermentation with full cell catalysis of Candida sp. 99-125 [J].
Chen, Changjing ;
Cai, Di ;
Qin, Peiyong ;
Chen, Biqiang ;
Wang, Zheng ;
Tan, Tianwei .
BIORESOURCE TECHNOLOGY, 2018, 257 :217-222
[5]   Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study [J].
Chen, Ruie ;
Wang, Shengpeng ;
Zhang, Jinming ;
Chen, Meiwan ;
Wang, Yitao .
DRUG DELIVERY, 2015, 22 (05) :666-674
[6]   Preparation and evaluation of self-microemulsifying delivery system containing 5-demethyltangeretin on inhibiting xenograft tumor growth in mice [J].
Chou, Ya-Chun ;
Li, Shiming ;
Ho, Chi-Tang ;
Pan, Min-Hsiung .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 579
[7]   LIPID MICROEMULSIONS FOR IMPROVING DRUG DISSOLUTION AND ORAL ABSORPTION - PHYSICAL AND BIOPHARMACEUTICAL ASPECTS [J].
CONSTANTINIDES, PP .
PHARMACEUTICAL RESEARCH, 1995, 12 (11) :1561-1572
[8]   Zingerone attenuates diabetic nephropathy through inhibition of nicotinamide adenine dinucleotide phosphate oxidase 4 [J].
Cui, Yan ;
Shi, Yan ;
Bao, Yan ;
Wang, Shulong ;
Hua, Qiuju ;
Liu, Yun .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 99 :422-430
[9]   Preparation and Bioavailability Assessment of SMEDDS Containing Valsartan [J].
Dixit, Adhvait R. ;
Rajput, Sadhana J. ;
Patel, Samir G. .
AAPS PHARMSCITECH, 2010, 11 (01) :314-321
[10]   Formulate-ability of ten compounds with different physicochemical profiles in SMEDDS [J].
Do Thi, Thao ;
Van Speybroeck, Michiel ;
Barillaro, Valery ;
Martens, Johan ;
Annaert, Pieter ;
Augustijns, Patrick ;
Van Humbeeck, Jan ;
Vermant, Jan ;
Van den Mooter, Guy .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (05) :479-488